Table 2. Indicators for Ethiopia to reach a reduction in premature CVD and related mortality by 2025.

Indicators	Baseline	Target by 2025
Reduce overall premature mortality from CVD		25% relative reduction
Reduce prevalence of current tobacco use ≥in persons ≥15 years	5%	30% relative reduction
Reduce harmful use of alcohol in persons ≥ 15 years	12.5% NCD STEPS in 2015*	10% relative reduction
Reduce prevalence of current khat use in persons ≥ 15 years	16% NCD STEPS in 2015*	20% relative
Reduce prevalence of insufficient PA in persons ≥ 15 years	5.8% NCD STEPS in2015*	10% relative reduction
Reduce mean population salt intake to < 5 g per day in persons ≥ 15 years	8.3 g NCD STEPS in 2015*	30% relative reduction
Reduce mean population salt intake to < 5 g per day in persons ≥ 15 years	8.3 g NCD STEPS in 2015*	30% relative reduction
Reduce insufficient fruit and vegetable consumption in persons ≥ 15 years	97.6% STEPS in 2015*	25% relative reduction
Reduce the percentage of people who are obese or overweight	6.3% STEPS in 2015*	15% relative reduction
Reduce the age-standardised prevalence of raised TC among persons ≥ 18 years	5.6% STEPS in 2015*	10% relative reduction
Reduce prevalence of raised BP in persons ≥ 15 years	16% STEPS in 2015*	25% relative reduction
Reduction in the prevalence of ARF/RHD in the 4–24-year-old age group	17/1 000 school children and young adults**	25% relative reduction
Increase treatment (pharmacological and non-pharmacological) coverage for patients with hypertension	Baseline 28% of diagnosed based on the NCDI commission report**	50%
Increase the proportion of people with hypertension with controlled BP	26% based on the NCDI commission report**	60%
Halt increase in prevalence of raised blood sugar in persons ≥ 15 years	3.2% STEPS in 2015*	0% increase
Increase the proportion of people with diabetes with controlled blood glucose level	24% based on the NCDI commission report**	60%
Increase treatment coverage for patients with diabetes (pharmacological and nonpharmacological)	3% STEPS 2015*	50%
Increase availability of basic technologies and essential medicines (including generics) required to treat CVD in public and private facilities	Availability based on the SARA 2018 report#	80%
Decrease household air pollution from biomass fuel use	Baseline > 90% households use biomass fuel	< 60%

CVD, cardiovascular diseases; NCD, non-communicable diseases; STEPS, step-wise survey; PA, physical activity; TC, total cholesterol; BP, blood pressure; ARF/RHD, acute rheumatic fever/rheumatic heart disease.

*STEPS report;¹² **NCDI commission report;⁴⁹ #SARA 2018 report.²⁵